Aralia taibaiensis protects cardiac myocytes against high glucose-induced oxidative stress and apoptosis

American Journal of Chinese Medicine

Volumn 43, Issue 6, 2015, Pages 1159-1175

  Duan, Jialin ^a   Wei, Guo ^a   Guo, Chao ^a   Cui, Jia ^a   Yan, Jiajia ^a   Yin, Ying ^a   Guan, Yue ^a   Weng, Yan ^a   Zhu, Yanrong ^a   Wu, Xiaoxiao ^a   Wang, Yanhua ^a   Xi, Miaomiao ^a   Wen, Aidong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hyperglycemia; Nfr2; Reactive Oxygen Species; Saponins of Aralia taibaiensis; Type 2 Diabetes

Indexed keywords

ANTIDIABETIC AGENT; CYTOPROTECTIVE AGENT; GLUCOSE OXIDASE; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SAPONIN DERIVATIVE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; GLUCOSE; HERBACEOUS AGENT; NFE2L2 PROTEIN, RAT; PROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARALIA; ARALIA TAIBAIENSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; GLUCOSE INTAKE; HEART MUSCLE CELL; HEART PROTECTION; HYPERGLYCEMIA; LIPID PEROXIDATION; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM;

ANIMALS; APOPTOSIS; ARALIA; CELL CULTURE TECHNIQUES; DRUGS, CHINESE HERBAL; GLUCOSE; HUMANS; MYOCYTES, CARDIAC; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84943538791     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X15500664     Document Type: Article

References (32)

1. Cai L.,Y.J. Kang Oxidative stress and diabetic cardiomyopathy. Cardiovasc. Toxicol. 3, 181-193, 2001.
2. Cai, L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic. Biol. Med. 41: 851-861, 2006.
3. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 82: 47-95, 2002.
4. Dhalla, N.S., A.B. Elmoselhi, T. Hata and N. Makino. Status of myocardial antioxidants in ischemiareperfusion injury. Cardiovasc. Rev. 47: 446-456, 2000.
5. Eriksson, U.J. and L.A. Borg. Diabetes and embryonic malformations: Role of substrate induced freeoxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 3: 411-419, 1993.
6. Evans, J.L., I.D. Goldfine, B.A. Maddux and G.M. Grodsky. Are oxidative stress activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003.
7. Finkel, T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10: 248-253, 1998.
8. Forman, H.J. and M. Torres. Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care. Med. 166: S4-S8, 2002.
9. Francis, G.S. Diabetic cardiomyopathy: Fact or fiction. Heart 85: 247-248, 2001.
10. Hayat, S.A., B. Patel, R.S. Khattar and R.A. Malik. Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment. Clin. Sci. (Lond) 107: 539-557, 2004.
11. Hiai, S., H. Oura and T. Nakajima. Color reaction of some sapogenins and saponins with vanillin sulphuric acid. Planta Med. 29: 116-122, 1976.
12. Ishii, T., K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai and M. Yamamoto. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol . Chem. 275: 16023-16029, 2000.
13. Jang, Y.J., J.K. Kim and M.S. Lee. Hypoglycemic and hypolipidemic effects of crude saponin fractions from Panax ginseng and Gynostemma pentaphyllum. Yakhak. Hoechi. 45: 545-556, 2001.
14. Kaul, N., N. Siveski-Iliskovic, M. Hill, N. Khaper, C. Seneviratne and P.K. Singal. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol. Cell. Biochem. 160-161: 283-288, 1996.
15. Kourie, J.I. Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 275: C1-C24, 1998.
16. Kretz-Remy, C. and A.P. Arrigo. Gene expression and the thiol redox state. Methods Enzymol. 348: 200-215, 2002.
17. Kumar, D. and B. Jugutt. Apoptosis and oxidants in the heart. J. Lab. Clin. Med. 5: 288-297, 2003.
18. Li, Y.N., Y. Guo, M.M. Xi, P. Yang, X.Y. Zhou, S. Yin, C.X. Hai, J.G. Li and X.J. Qin. Saponins from Aralia taibaiensis attenuate D-galactose-induced aging in rats by activating FOXO3a and Nrf2 pathways. Oxid. Med. Cell Longev. 2014: 320513, 2014.
19. Liu, H., R. Colavitti, I.I. Rovira and T. Finkel. Redox-dependent transcriptional regulation. Circ. Res. 97: 967-974, 2005.
20. Mann, G.E., J. Niehueser-Saran, A. Watson, L. Gao, T. Ishii, P. Winter and R.C. Siow. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: Implications for atherosc lerosis and preeclampsia. Sheng Li Xue Bao 59: 117-127, 2007.
21. Maulik, N., H.S. Sharma and D.K. Das. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J. Mol. Cell. Cardiol. 6: 1261-1270, 1996.
22. Nishikawa, T., D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino and M. Brownlee. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 6779: 787-790, 2000.
23. Nishio Y.,A. Kashiwagi,H. Taki,K. Shinozaki,Y. Maeno,H. Kojima,H. Maegawa,M. Haneda,H. Hidaka,H. Yasuda,K. Horiike,R. Kikkawa. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats Diabetes 8 1318-1325 1998.
24. Ramos-Gomez, M., M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, P. Talalay and T.W. Kensler. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers i s lost in Nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98: 3410-3415, 2001.
25. Rhee, S.G., S.W. Kang, W. Jeong, T.S. Chang, K.S. Yang and H.A. Woo. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17: 183-189, 2005.
26. Trost, S and M. LeWinter. Diabetic cardiomyopathy. Curr. Treatment. Opt. Cardiovasc. Med. 3: 481-492, 2001.
27. Weng, Y., L. Yu, J. Cui, Y.R. Zhu, C. Guo, G. Wei, J.L. Duan, Y. Yin, Y. Guan, Y.H. Wang, Z.F. Yang, M.M. Xi and A.D. Wen. Antihyperglycemic, hypolipidemic and antioxidant ac tivities of total saponins extracted from Aralia taibaiensis in experimental type 2 diabetic rats. J. Ethnopharmacol. 152: 553-560, 2014.
28. Wohaieb, S.A. and D.V. Godin. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat: Effects of insulin treatment. Diabetes 36: 1014-1018, 1987.
29. Wolff, S.P., Z.Y. Jiang and J.V. Hunt. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic. Biol. Med. 5: 339-352, 1991.
30. Xi, M.M., C.X. Hai, H.F. Tang, M. Chen, K. Fang and X. Liang. Antioxidant and antiglycation properties of total saponins extracted from trad itional Chinese medicine used to treat diabetes mellitus. Phytother. Res. 22: 228-237, 2008.
31. Xi, M.M., C.X. Hai, H.F. Tang, A.D. Wen, H.L. Chen, R. Liu, X. Liang and M.S. Chen. Antioxidant an d antiglycation properties of triterpenoid saponins from Aralia taibaiensis traditionally used for treating diabetes mellitus. Redox. Report. 1: 20-28, 2010.
32. Zimmet, P., K.G. Alberti and J. Shaw. Global and soci etal implications of the diabetes epidemic. Nature 414: 782-787, 2001.